Article
The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa
2023-08-31
Abstract excerpt
<h4>Background</h4> Alzheimer’s Disease (AD), the most common cause of dementia, poses a significant global burden. Diagnosis typically involves invasive and costly methods like neuroimaging or cerebrospinal fluid (CSF) biomarker testing of phosphorylated tau (p-tau) and amyloid-β 42/40 (Aβ 42/40 ). Such procedures are especially impractical in resource-constrained regions, such as the Democratic Republic of Congo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b2fa2dcb-4467-5d56-8be0-514d2efb2d21
- DOI
- 10.1101/2023.08.28.23294740
